Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.02 USD | +5.04% | +23.85% | -42.82% |
Mar. 22 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
Mar. 21 | Cabaletta Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.82% | 598M | |
+8.84% | 105B | |
-0.78% | 104B | |
+5.79% | 22.94B | |
-12.38% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-8.78% | 16.96B | |
+8.21% | 14.16B | |
+39.56% | 12.63B |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- Transcript : Cabaletta Bio, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 05